Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ROS in hepatocellular carcinoma: What we know
Lin Xing, Yu-Ting Tang, Lu Li, et al.
Archives of Biochemistry and Biophysics (2023) Vol. 744, pp. 109699-109699
Closed Access | Times Cited: 11

Showing 11 citing articles:

Underlying Mechanisms behind the Brain–Gut–Liver Axis and Metabolic-Associated Fatty Liver Disease (MAFLD): An Update
Júlia Pauli De Cól, Enzo Pereira de Lima, Fernanda Moris Pompeu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3694-3694
Open Access | Times Cited: 10
Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors
Hao Li, Shuai Wang, Zhengqiang Yang, et al.
Bioactive Materials (2024) Vol. 36, pp. 376-412
Open Access | Times Cited: 8
Mitochondrial alterations and signatures in hepatocellular carcinoma
Tsung‐Hsien Chen, Shu-Hsien Lin, Ming‐Yang Lee, et al.
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
The tumor distance to the main hepatic vessels is a predictor of recurrence-free survival and overall survival in hepatocellular cancer
Schaima Abdelhadi, Johann S. Rink, Matthias F. Froelich, et al.
Langenbeck s Archives of Surgery (2025) Vol. 410, Iss. 1
Open Access
Efficacy assessment of glycyrrhetinic acid-modified liposomes loaded with doxorubicin hydrochloride and cucurbitine B for synergistic treatment of hepatocellular carcinoma
Muhan Chen, Xinze Liu, Lingchao Kong, et al.
International Journal of Pharmaceutics (2025), pp. 125360-125360
Closed Access
Gene Expression Reprogramming by Citrate Supplementation Reduces HepG2 Cell Migration and Invasion
Rocchina Miglionico, Ilenia Matera, Giovanna Maria Ventola, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6509-6509
Open Access | Times Cited: 1
Transcriptomic analysis of Paraoxonase 1 expression in hepatocellular carcinoma and its potential impact on tumor immunity
Linxiao Dong, Changjun Dong, Yunlin Yu, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 1
HCV and HCC Tango—Deciphering the Intricate Dance of Disease: A Review Article
Ivana Milošević, Nevena Todorović, Ana Filipović, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16048-16048
Open Access | Times Cited: 3
Effects of Zinc Phthalocyanine Photodynamic Therapy on Vital Structures and Processes in Hela Cells
Jakub Hošík, Barbora Hošíková, Svatopluk Binder, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10650-10650
Open Access
A new opportunity for N-acetylcysteine. An outline of its classic antioxidant effects and its pharmacological potential as an epigenetic modulator in liver diseases treatment
Marina Galicia‐Moreno, Hugo Christian Monroy-Ramírez, Fernando Caloca-Camarena, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
BIRC5 knockdown ameliorates hepatocellular carcinoma progression via regulating PPARγ pathway and cuproptosis
Yanxing Mai, Zhongzhong Ji, Yujing Tan, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Page 1

Scroll to top